Floatz logo

Realgar-Indigo Naturalis Formulation

Childhood ALL

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityPhase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

70 Active assets in the Childhood ALL cohort.

Asset / SponsorPhaseRating
VINCRISTINE SULFATE
National Cancer Institute (NCI)
Phase 3BBB
MERCAPTOPURINE ANHYDROUS
Children's Oncology Group
Phase 3BBB
Cyclophosphamide
St. Jude Children's Research Hospital
Phase 3BBB
FILGRASTIM
St. Jude Children's Research Hospital
Phase 3BBB
Cytosin-Arabinosid
Children's Oncology Group
Phase 3BBB

View all 50 →

Same molecule, other indications

Realgar-Indigo Naturalis Formulation is also rated in:

acute promyelocytic leukemiaDormant
BB
Indicative ·
66 / 100
View asset →
ovarian cancerDormant
BB
Indicative ·
65 / 100
View asset →
Arsenic TrioxideDormant
BB
Indicative ·
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →